Also, we observed down‐regulation of the lipolytic CPT1 and the adipokine ADIPOQ, the expression of which has been described in the modulation of insulin sensitivity in 3T3‐L1 cells [Fasshauer et al., 2002], after CML treatment. The gene discussed is ADIPOQ; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.